Cash Flow Statement

Altimmune (ALT) Net Margin (QoQ) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Altimmune 379.61 Mn 379.61 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 60.29 Mn
Sep 30, 2025 6.26 Mn
Jun 30, 2025 -5.14 Mn
Mar 31, 2025 7.21 Mn
Dec 31, 2024 -670,000.00
Sep 30, 2024 3.59 Mn
Jun 30, 2024 -492,000.00
Mar 31, 2024 -46.39 Mn
Dec 31, 2023 -1.83 Mn
Sep 30, 2023 26.39 Mn
Jun 30, 2023 -17.39 Mn
Mar 31, 2023 -29.22 Mn
Dec 31, 2022 137.23 Mn
Sep 30, 2022 -92.42 Mn
Jun 30, 2022 -19.06 Mn
Mar 31, 2022 -6.09 Mn
Dec 31, 2021 2.10 Mn
Sep 30, 2021 -308,718.00
Jun 30, 2021 -1.63 Mn
Mar 31, 2021 -131,448.00
Dec 31, 2020 14,556.00
Sep 30, 2020 -24,810.00
Jun 30, 2020 -18,114.00
Mar 31, 2020 53,586.00
Dec 31, 2019 98,724.00
Sep 30, 2019 -149,042.00
Jun 30, 2019 -12,201.00
Mar 31, 2019 89,060.00
Dec 31, 2018 -89,007.00
Sep 30, 2018 32,024.00
Jun 30, 2018 -21,883.00
Mar 31, 2018 47,096.00
Dec 31, 2017 3,481.00
Sep 30, 2017 -59,013.00
Jun 30, 2017 146,410.00
Mar 31, 2017 -128,361.00
Dec 31, 2016 9.89 Mn
Sep 30, 2016 -9.89 Mn
Jun 30, 2016 -16,808.00
Mar 31, 2016 -2,422.00
Dec 31, 2015 1,683.00
Sep 30, 2015 8,902.00
Jun 30, 2015 -22,434.00
Mar 31, 2015 16,468.00
Dec 31, 2014 33,693.00
Sep 30, 2014 -46,890.00
Jun 30, 2014 4,834.00
Mar 31, 2014 6,075.00
Dec 31, 2013 -797.00
Sep 30, 2013 -8,434.00
Jun 30, 2013 382.00
Mar 31, 2013 -1,149.00
Dec 31, 2012 -1,792.00
Sep 30, 2012 878.00
Jun 30, 2012 3,161.00
Mar 31, 2012 -5,559.00
Dec 31, 2011 1,264.00
Sep 30, 2011 3,728.00
Jun 30, 2011 -517.00
Mar 31, 2011 11,848.00
Dec 31, 2010 -8,219.00
Sep 30, 2010 6,603.00